title: Reimbursement programs and health technology assessment for diabetes devices and supplies: a Canadian perspective.
abstract: The reimbursement model for medical devices and supplies used in the management of diabetes in Canada, along with the process for assessing new health technologies, can be complicated. Various provincial programs, including Ontario's Assistive Devices Program and the Ontario Monitoring for Health Program, reimburse the costs associated with certain devices and supplies for diabetes management. In addition, provincial advisory committees, such as the Ontario Health Technology Advisory Committee, review and make recommendations on the adoption of new health technologies in each province. This article provides an overview of the reimbursement programs available for diabetes devices and supplies and reviews the process for assessing new health technologies using the province of Ontario as an example.
authors.affiliation: Fasken Martineau DuMoulin LLP, Toronto, Ontario, Canada rcheung@fasken.com.
authors.forename: Richard Y
authors.initials: RY
authors.lastname: Cheung
authors.affiliation: Fasken Martineau DuMoulin LLP, Toronto, Ontario, Canada.
authors.forename: Vanessa
authors.initials: V
authors.lastname: Mui
mesh_terms: D020811:Biomedical Technology / Q000191:economics* / Q000592:standards*; D003365:Costs and Cost Analysis; D003920:Diabetes Mellitus / Q000191:economics* / Q000628:therapy*; D006801:Humans; D018803:Models, Economic; D009864:Ontario; D012051:Reimbursement Mechanisms; D013673:Technology Assessment, Biomedical / Q000191:economics* / Q000592:standards*
keywords: cost; diabetes; health technology assessment; reimbursement